Bencherifi Y, Watik F, Lyafi Y, Mostapha B, Ennachit M, Mohammed EK. Serous ovarian cystadenofibroma and review of the literature: Report of a case.
Int J Surg Case Rep 2023;
110:108649. [PMID:
37639968 PMCID:
PMC10509793 DOI:
10.1016/j.ijscr.2023.108649]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 08/02/2023] [Accepted: 08/06/2023] [Indexed: 08/31/2023] Open
Abstract
INTRODUCTION AND IMPORTANCE
Ovarian cystadenofibroma is a relatively rare benign tumor (Groutz et al., 1994) that develops from the ovarian epithelium and stroma. This tumor can be solid, cystic, or semi-solid, depending on the fraction of epithelium and stroma it contains and the secretory activity of the epithelium that composes it.
CASE PRESENTATION
We report the case of a 58-year-old multiparous patient who consulted for pelvic pain and for whom an MRI was requested, objectifying the presence of a mass of ovarian origin. The patient had been menopausal since the age of 51 and was not taking hormone replacement therapy. She had comorbid hypertension for 4 years under treatment. Preoperative ultrasound showed an ovarian-appearing, finely echogenic mass, site of endocystic vegetation, measuring 8.48 mm × 7.30 mm long axis.
CLINICAL DISCUSSION
The mechanism underlying this hyperestrogenism is considered to be hypersecretion of the hormone by the tumor itself.
CONCLUSION
cystadenofibromas had morphologic imaging features of malignancy on CT or MR images. On histology, solid components in the cystic tumors were correlated with fibrous stromas that occasionally made a false positive result for malignancy on imaging.
Collapse